What is the share price of Bilcare Ltd (BI) today?
The share price of BI as on 4th July 2025 is ₹71.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Bilcare Ltd (BI) share?
The past returns of Bilcare Ltd (BI) share are- Past 1 week: -3.53%
- Past 1 month: -10.88%
- Past 3 months: -23.89%
- Past 6 months: -7.43%
- Past 1 year: 22.05%
- Past 3 years: 10.88%
- Past 5 years: 22.47%
What are the peers or stocks similar to Bilcare Ltd (BI)?
The peers or stocks similar to Bilcare Ltd (BI) include:What is the market cap of Bilcare Ltd (BI) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Bilcare Ltd (BI) is ₹168.40 Cr as of 4th July 2025.What is the 52 week high and low of Bilcare Ltd (BI) share?
The 52-week high of Bilcare Ltd (BI) is ₹97.99 and the 52-week low is ₹51.What is the PE and PB ratio of Bilcare Ltd (BI) stock?
The P/E (price-to-earnings) ratio of Bilcare Ltd (BI) is -5.85. The P/B (price-to-book) ratio is 0.26.Which sector does Bilcare Ltd (BI) belong to?
Bilcare Ltd (BI) belongs to the Health Care sector & Labs & Life Sciences Services sub-sector.How to buy Bilcare Ltd (BI) shares?
You can directly buy Bilcare Ltd (BI) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Bilcare Ltd
BI Share Price
71.502.28% (-1.67)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
BI Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
AvgCan be considered moderately valued vs the market
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
BI Performance & Key Metrics
BI Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -8.85 | 0.26 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 37.15 | 6.59 | 0.82% |
BI Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
BI Company Profile
Bilcare Limited offers pharmaceutical packaging solutions that are used in pharmaceutical products. It’s other packaging films solutions cater to various industries like ID card industry, specialty films applications and food packaging.
DIVISLAB
PE Ratio
83.68
83.68
1Y Return
51.99%
51.99%
Buy Reco %
47.83
47.83
SYNGENE
PE Ratio
52.16
52.16
1Y Return
11.24%
11.24%
Buy Reco %
71.43
71.43
AARTIPHARM
PE Ratio
29.96
29.96
1Y Return
46.35%
46.35%
Buy Reco %
0.00
0.00
PE Ratio
1,269.75
1,269.75
1Y Return
52.35%
52.35%
Buy Reco %
0.00
0.00
VIMTALABS
PE Ratio
31.15
31.15
1Y Return
81.09%
81.09%
Buy Reco %
0.00
0.00
BI Forecast
BI Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
BI
BI
Income
Balance Sheet
Cash Flow
Annual Normal View
BI Income Statement
BI Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,741.79 | 3,079.16 | 3,057.25 | 2,082.32 | 672.50 | 891.80 | 1,301.65 | 769.70 | 806.50 | 820.29 | ||||||||||
Raw Materials | 1,380.80 | 1,577.38 | 1,631.68 | 797.66 | 416.44 | 607.37 | 730.32 | 520.36 | 749.46 | 763.25 | ||||||||||
| Power & Fuel Cost | 118.24 | 118.81 | 119.84 | 73.64 | 29.80 | 34.35 | 42.84 | 39.64 | ||||||||||||
| Employee Cost | 524.42 | 558.54 | 616.93 | 370.78 | 55.30 | 59.27 | 71.26 | 71.87 | ||||||||||||
| Selling & Administrative Expenses | 142.51 | 136.43 | 163.51 | 104.35 | 20.46 | 28.01 | 31.87 | 25.46 | ||||||||||||
| Operating & Other expenses | 278.58 | 229.97 | 296.61 | 436.59 | 54.37 | 58.84 | 131.46 | 57.34 | ||||||||||||
EBITDA | 297.24 | 458.03 | 228.68 | 299.30 | 96.13 | 103.96 | 293.90 | 55.03 | 57.04 | 57.04 | ||||||||||
| Depreciation/Amortization | 176.95 | 416.19 | 378.36 | 238.80 | 45.51 | 39.25 | 37.81 | 44.95 | 45.88 | 45.88 | ||||||||||
| PBIT | 120.29 | 41.84 | -149.68 | 60.50 | 50.62 | 64.71 | 256.09 | 10.08 | 11.16 | 11.16 | ||||||||||
| Interest & Other Items | 176.35 | 249.06 | 282.84 | 174.16 | 75.59 | 68.93 | 60.00 | 81.79 | 82.50 | 82.50 | ||||||||||
| PBT | -56.06 | -207.22 | -432.52 | -113.66 | -24.97 | -4.22 | 196.09 | -71.71 | -71.34 | -71.34 | ||||||||||
| Taxes & Other Items | 28.47 | -6.07 | 22.58 | -10.11 | -3.88 | 8.37 | 181.04 | -38.47 | -42.56 | -52.31 | ||||||||||
| Net Income | -84.53 | -201.15 | -455.10 | -103.55 | -21.09 | -12.59 | 15.05 | -33.24 | -28.78 | -19.03 | ||||||||||
| EPS | -35.90 | -85.43 | -193.29 | -43.98 | -8.96 | -5.35 | 6.39 | -14.12 | -12.22 | -8.08 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
BI Company Updates
BI Stock Peers
BI Past Performance & Peer Comparison
BI Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareLabs & Life Sciences Services
Compare valuation-basic on Screener
Health CareLabs & Life Sciences Services
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Bilcare Ltd | -5.85 | 0.26 | — |
| Divi's Laboratories Ltd | 83.68 | 13.51 | 0.43% |
| Syngene International Ltd | 52.16 | 5.48 | 0.19% |
| Aarti Pharmalabs Ltd | 29.96 | 4.64 | 0.56% |
BI Stock Price Comparison
Compare BI with any stock or ETFCompare BI with any stock or ETF
BI
BI Holdings
BI Shareholdings
BI Promoter Holdings Trend
BI Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
BI Institutional Holdings Trend
BI Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 2.35%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
BI Shareholding Pattern
BI Shareholding Pattern
BI Shareholding History
BI Shareholding History
Foreign Institutions
smallcases containing BI stock
smallcases containing BI stock
Looks like this stock is not in any smallcase yet.
BI Events
BI Events
BI Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
BI has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
BI Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
BI has not given any dividends in last 5 years
BI Upcoming Dividends
BI Upcoming Dividends
No upcoming dividends are available
BI Past Dividends
BI Past Dividends
Cash Dividend
Ex DateEx DateSep 20, 2012
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Sep 20, 2012
Cash Dividend
Ex DateEx DateSep 20, 2011
Final
Final | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Sep 20, 2011
BI Stock News & Opinions
BI Stock News & Opinions
Articles & Videos
Earnings
Bilcare reports consolidated net profit of Rs 10.56 crore in the March 2025 quarter
Net profit of Bilcare reported to Rs 10.56 crore in the quarter ended March 2025 as against net loss of Rs 10.89 crore during the previous quarter ended March 2024. Sales declined 3.02% to Rs 194.03 crore in the quarter ended March 2025 as against Rs 200.07 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 28.78 crore in the year ended March 2025 as against net loss of Rs 33.23 crore during the previous year ended March 2024. Sales rose 5.47% to Rs 788.04 crore in the year ended March 2025 as against Rs 747.18 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales194.03200.07 -3 788.04747.18 5 OPM %3.81-4.13 -5.665.24 - PBDT-3.73-25.79 86 -19.41-20.12 4 PBT-15.31-39.19 61 -65.29-65.07 0 NP10.56-10.89 LP -28.78-33.23 13 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Bilcare schedules board meeting
Bilcare will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Bilcare reports consolidated net loss of Rs 7.17 crore in the December 2024 quarter
Net Loss of Bilcare reported to Rs 7.17 crore in the quarter ended December 2024 as against net loss of Rs 6.85 crore during the previous quarter ended December 2023. Sales rose 13.26% to Rs 198.13 crore in the quarter ended December 2024 as against Rs 174.94 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales198.13174.94 13 OPM %5.389.86 - PBDT-5.390.47 PL PBT-17.13-10.10 -70 NP-7.17-6.85 -5 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Bilcare to table results
Bilcare will hold a meeting of the Board of Directors of the Company on 13 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Bilcare reports consolidated net loss of Rs 16.03 crore in the September 2024 quarter
Net Loss of Bilcare reported to Rs 16.03 crore in the quarter ended September 2024 as against net loss of Rs 7.59 crore during the previous quarter ended September 2023. Sales rose 6.22% to Rs 201.74 crore in the quarter ended September 2024 as against Rs 189.92 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales201.74189.92 6 OPM %3.798.79 - PBDT-12.127.15 PL PBT-23.16-3.33 -595 NP-16.03-7.59 -111 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Bilcare to conduct board meeting
Bilcare will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Bilcare AGM scheduled
Bilcare announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Earnings
Bilcare standalone net profit declines 89.57% in the June 2024 quarter
Net profit of Bilcare declined 89.57% to Rs 1.40 crore in the quarter ended June 2024 as against Rs 13.42 crore during the previous quarter ended June 2023. Sales rose 33.06% to Rs 4.87 crore in the quarter ended June 2024 as against Rs 3.66 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales4.873.66 33 OPM %-17.45-39.62 - PBDT2.36-0.99 LP PBT1.63-1.43 LP NP1.4013.42 -90 Powered by Capital Market - Live
10 months agoCapital Market - Live
Earnings
Bilcare reports consolidated net loss of Rs 6.39 crore in the June 2024 quarter
Net Loss of Bilcare reported to Rs 6.39 crore in the quarter ended June 2024 as against net loss of Rs 7.91 crore during the previous quarter ended June 2023. Sales rose 6.52% to Rs 194.14 crore in the quarter ended June 2024 as against Rs 182.25 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales194.14182.25 7 OPM %9.767.39 - PBDT1.83-1.95 LP PBT-9.69-12.45 22 NP-6.39-7.91 19 Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Bilcare to table results
Bilcare will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -17.28%, vs industry avg of 7.5%
Over the last 5 years, market share decreased from 17.09% to 4.07%